Dr.T.Braeckevelt – klinische biologie
0884.531.419 · rovalta.com · 27/09/2026
ACTIVE
Dr.T.Braeckevelt – klinische biologie
Financial year 2025 · Closed on 30/06/2025
Net result174,9 k €+28,5 %over 1 year
Gross margin305,2 k €+24,9 %over 1 year
Equity1,8 M €+7,3 %over 1 year
Workforce0,0 ETP
Overview
Identity
Source · BCE/KBODr.T.Braeckevelt – klinische biologie is a Private limited company incorporated in 2006. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Ronse.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0884.531.419
- Incorporation
- 25/10/2006
- Legal form
- Private limited company
- Registered office
- Rue du Maquis 231
9600 Ronse · FlandreSee on map - Contributed capital
- 156 660,00 €
- Latest accounts
- 30/06/2025
- Average workforce
- 0,0 ETP
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 19 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 305,2 k € | +24.9% | 244,4 k € | -22.3% | 314,6 k € | -50.4% | 634,9 k € | +114% | 296,8 k € |
| EBITDA | 297,7 k € | +25.3% | 237,5 k € | -22.3% | 305,7 k € | -51.3% | 627,3 k € | +103% | 308,5 k € |
| Operating result | 218,5 k € | +15.8% | 188,8 k € | -26.7% | 257,6 k € | -56.2% | 588 k € | +120% | 267,2 k € |
| Net result | 174,9 k € | +28.5% | 136,1 k € | -25.0% | 181,5 k € | -55.1% | 404,2 k € | +139% | 169,4 k € |
| Balance sheet | |||||||||
| Equity | 1,8 M € | +7.3% | 1,7 M € | +2.2% | 1,7 M € | +12.2% | 1,5 M € | +92.4% | 776,1 k € |
| Total assets | 2 M € | +6.5% | 1,8 M € | +0.7% | 1,8 M € | +0.0% | 1,8 M € | +43.1% | 1,3 M € |
| Cash | 191 k € | -74.1% | 738,4 k € | -33.6% | 1,1 M € | +16.2% | 956,1 k € | +94.6% | 491,4 k € |
| Debts | 58 k € | -10.0% | 64,4 k € | -27.7% | 89,1 k € | -67.0% | 270 k € | -35.2% | 416,5 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thierry Braeckevelt | Director | 000 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thierry BRAECKEVELT | Manager | 000 |
Other companies at this address
Rue du Maquis 231 9600 Ronse| Company | CBE no. |
|---|---|
GROEP BRAECKEVELT● Active | 1029.108.434 |
MONTHI● Active | 0459.963.112 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 02/02/2026 | 18/02/2025 | 08/02/2024 | 13/01/2023 | 04/01/2022 | 18/03/2021 |
| General meeting | 23/01/2026 | 15/11/2024 | 17/11/2023 | 18/11/2022 | 19/11/2021 | 20/11/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2025 | 23/01/2026 | 02/02/2026 | Dutch | |
| Abridged model | 30/06/2024 | 15/11/2024 | 18/02/2025 | Dutch | |
| Abridged model | 30/06/2023 | 17/11/2023 | 08/02/2024 | Dutch | |
| Micro model | 30/06/2022 | 18/11/2022 | 13/01/2023 | Dutch | |
| Abridged model | 30/06/2021 | 19/11/2021 | 04/01/2022 | Dutch | |
| Abridged model | 30/06/2020 | 20/11/2020 | 18/03/2021 | Dutch | |
| Abridged model | 30/06/2019 | 15/11/2019 | 30/01/2020 | Dutch | |
| Abridged model | 30/06/2018 | 16/11/2018 | 01/02/2019 | Dutch | |
| Abridged model | 30/06/2017 | 08/12/2017 | 01/02/2018 | Dutch | |
| Abridged model | 30/06/2016 | 18/11/2016 | 10/03/2017 | Dutch | |
| Abridged model | 30/06/2015 | 20/11/2015 | 08/03/2016 | Dutch | |
| Abridged model | 30/06/2014 | 21/11/2014 | 26/02/2015 | Dutch | |
| Abridged model | 30/06/2013 | 21/11/2013 | 28/02/2014 | Dutch | |
| Abridged model | 30/06/2012 | 16/11/2012 | 08/02/2013 | Dutch | |
| Abridged model | 30/06/2011 | 18/11/2011 | 13/12/2011 | Dutch | |
| Abridged model | 30/06/2010 | 19/11/2010 | 01/03/2011 | Dutch | |
| Abridged model | 30/06/2009 | 20/11/2009 | 10/03/2010 | Dutch | |
| Abridged model | 30/06/2008 | 21/11/2008 | 17/04/2009 | Dutch | |
| Abridged model | 30/06/2007 | 16/11/2007 | 29/02/2008 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thierry Braeckevelt | Director | 000 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thierry BRAECKEVELT | Manager | 000 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates10/11/2023WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
- Capital / shares02/07/2014KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other26/11/2010DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other06/11/2006RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025174,9 k €↑
- 2024Annual accounts 2024136,1 k €↓
- 2023Annual accounts 2023181,5 k €↓
- 2023Name changeDr.T.Braeckevelt – klinische biologie
- 2022Annual accounts 2022404,2 k €↑
- 2019Annual accounts 2019169,4 k €↑
- 2018Annual accounts 201899 k €↑
- 2017Annual accounts 201788 k €↓
- 2016Annual accounts 201699,2 k €↑
- 2015Annual accounts 201548,6 k €↓
- 2014Annual accounts 201453 k €↑
- 2013Annual accounts 201350,3 k €↓
- 2012Annual accounts 2012170,4 k €↑
- 2011Annual accounts 2011104,9 k €↓
- 2010Annual accounts 2010137,4 k €↓
- 2009Annual accounts 2009187,8 k €↑
- 2008Annual accounts 2008164,5 k €↑
- 2007Annual accounts 2007-100,2 k €
- 25/10/2006IncorporationPrivate limited company
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr.T.Braeckevelt – klinische biologieCurrent | accounts 2023 → 2025 · CBE, tracked since 27/09/2026 | Accounts 2025 · 2026-00027644 |
| BRAECKEVELT | accounts 2022 | Accounts 2022 · 2023-00001520 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.